ASHLEY BRINKLEY: Open Payments
NPI 1891096632 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$681 in 27 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $40 · 2025 $681
Food & beverage: $681
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 8 | $225 |
| Eisai Inc. | 4 | $113 |
| Daiichi Sankyo Inc. | 3 | $79 |
| ABBVIE INC. | 2 | $50 |
| Astellas Pharma US Inc | 2 | $39 |
| Genmab U.S., Inc. | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $26 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| Corcept Therapeutics | 1 | $25 |
| Provepharm Inc. | 1 | $24 |
Products named: KEYTRUDA, Lenvima, Enhertu, ELAHERE, Veozah, Epkinly, JEMPERLI, Vitrakvi.
Industry payments across TN — which companies pay providers there.
